| 2201 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2202 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
13 |
| 2203 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2204 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
32 |
| 2205 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2206 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2207 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2208 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2209 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2210 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2211 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
75 |
| 2212 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2213 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
13 |
| 2214 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2215 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2216 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
34 |
| 2217 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2218 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy (Ald) – Siemerling-Creutzfeldt Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2219 |
Bone Marrow |
Allogeneic |
Amegakaryocytic Thrombocytopenia |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2220 |
Bone Marrow |
Allogeneic |
Anemia Fanconi |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2221 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
18 |
| 2222 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2223 |
Bone Marrow |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2224 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2225 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2226 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2227 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2228 |
Bone Marrow |
Allogeneic |
Chronic Myeloid Leukemia Blast Crisis |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2229 |
Bone Marrow |
Allogeneic |
Clippers Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2230 |
Bone Marrow |
Allogeneic |
Congenital Amegakaryocytic Thrombocytopenia (Camt) |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2231 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2232 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2233 |
Bone Marrow |
Allogeneic |
Hodgkin’s Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
23 |
| 2234 |
Bone Marrow |
Allogeneic |
Immunodeficiency – Xlp1 |
Hematology |
2023 |
Standard Therapy |
Poland |
10 |
| 2235 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2236 |
Bone Marrow |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2237 |
Bone Marrow |
Allogeneic |
Metachromatic Leukodystrophy |
Hematology |
2023 |
Standard Therapy |
Poland |
22 |
| 2238 |
Bone Marrow |
Allogeneic |
Mitochondrial Neurogastrointestinal Encephalopathy |
Hematology |
2023 |
Standard Therapy |
Poland |
33 |
| 2239 |
Bone Marrow |
Allogeneic |
Mixed Lineage Acute Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2240 |
Bone Marrow |
Allogeneic |
Monocytopenia And Mycobacterial Infection (Monomac) Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2241 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type I |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2242 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type IH (Hurler) |
Hematology |
2023 |
Standard Therapy |
Poland |
8 months |
| 2243 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type Iv |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2244 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2245 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2246 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2247 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2248 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2249 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
19 |
| 2250 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2251 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2252 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2253 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2254 |
Bone Marrow |
Allogeneic |
Other Immune System |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2255 |
Bone Marrow |
Allogeneic |
Other Immune System |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2256 |
Bone Marrow |
Allogeneic |
Primary Combined Severe Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2257 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2258 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2259 |
Bone Marrow |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2260 |
Bone Marrow |
Allogeneic |
Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2261 |
Bone Marrow |
Allogeneic |
Secondary Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2262 |
Bone Marrow |
Allogeneic |
Secondary Myelofibrosis Post Polycythemia Vera |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2263 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2264 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2265 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
31 |
| 2266 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2267 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2268 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2269 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2270 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
81 |
| 2271 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
29 |
| 2272 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2273 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2274 |
Bone Marrow |
Allogeneic |
Sickle Cell Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2275 |
Bone Marrow |
Allogeneic |
T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2276 |
Bone Marrow |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2277 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2278 |
Bone Marrow |
Allogeneic |
Very Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2279 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2280 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2281 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
67 |
| 2282 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2283 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2284 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2285 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
58 |
| 2286 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2287 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2288 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2289 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2290 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
52 |
| 2291 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2292 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2293 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2294 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2295 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2296 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
40 |
| 2297 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2298 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
35 |
| 2299 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2300 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |